LDL cholesterol estimation using the Anandaraja's and Friedewald's formulas in schizophrenic patients treated with antipsychotic drugs

Clinical Biochemistry

Volumn 41, Issue 12, 2008, Pages 1002-1007

  Paz, Eduardo ^a   Hermida, Jesús ^b   Bouzas, Lorena ^b   Brenlla, Julio ^c   Tutor, J Carlos ^b  

^a Hôpital Psychiatrique de Conxo   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Anandaraja formula; Electrophoresis; Friedewald formula; LDL cholesterol; Metabolic syndrome

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CLOTIAPINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEVOMEPROMAZINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEUROLEPTIC AGENT; PIMOZIDE; QUETIAPINE; RISPERIDONE; SULPIRIDE; ZUCLOPENTHIXOL;

ACCURACY; ADULT; AGAR GEL ELECTROPHORESIS; AGED; ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POLYPHARMACY; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; AGED; ALGORITHMS; ANTIPSYCHOTIC AGENTS; BIOLOGICAL MARKERS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CLOZAPINE; ELECTROPHORESIS, AGAR GEL; FEMALE; HUMANS; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; SCHIZOPHRENIA; TRIGLYCERIDES;

EID: 47349116320     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.04.017     Document Type: Article

References (26)

1. Jindal R., MacKenzie E.M., Baker G.B., and Yeranagi V.K. Cardiac risk and schizophrenia. J Psychiatry Neurosci 30 (2005) 393-395
2. Tarricone I., Casoria I., Cozzi B.F., et al. Metabolic risk factor profile associated with use of second generation antipsychotics: a cross sectional study in a community mental health centre. BMC Psichiatry 6 (2006) 11
3. Wirshing D., Boy J.A., Meng L.R., Ballon J.S., Marder S.R., and Wirshing W.C. The effects of novel antipsychotics on glucose and lipids levels. J Clin Psychiatry 63 (2002) 856-865
4. Meyer J.M., and Koro C.E. The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophr Res 70 (2004) 1-17
5. Wang T.Y., Haddad M., and Wang T.S. Low triglyceride levels affect calculation of low-density lipoprotein cholesterol values. Arch Pathol Lab Med 125 (2001) 404-405
6. Scharnagl H., Nauck M., Wieleand H., and März W. The Friedewald formula underestimates LDL cholesterol at low concentrations. Clin Chem Lab Med 39 (2001) 426-431
7. Tremblay A.J., Morrisette H., Gagné J.M., Bergeron J., Gagné C., and Couture P. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with ß-quantification in a large population. Clin Biochem 37 (2004) 785-790
8. Mendes de Cordova M.M., Schneider C.R., Juttel L.D., and Mendes de Cordova M.M. Comparison of LDL cholesterol direct measurement with the estimate using the Friedewald formula in a sample of 10,664 patients. Arquiv Bras Cardiol 83 (2004) 482-487
9. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoproteins cholesterol in plasma without use of the ultracentrifuge. Clin Chem 18 (1972) 499-502
10. Hattori Y., Suzuki M., Tsushima M., et al. Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol/LDL-apo B as indices of hyperapobetaproteinemia and small dense LDL. Atherosclerosis 138 (1998) 289-299
11. Puavilai W., and Laoragpongse D. Is calculated LDL-C by using the new modified Friedewald equation better than the standard Friedewald equation?. J Med Assocc Thai 87 (2004) 589-593
12. Hata Y., and Nakajima K. Application of Friedewald's LDL-cholesterol estimation formula to serum lipids in Japanese population. Jpn Circ J 50 (1986) 1191-1200
13. Anandaraja S., Narang R., Godeswar R., Laksmy R., and Talwar K.K. Low-density lipoprotein cholesterol estimation by a new formula in Indian population. Int J Cardiol 102 (2005) 117-120
14. Gasko R. Low-density lipoprotein cholesterol estimation by a new formula - confirmation. Int J Cardiol 119 (2007) 242-243
15. Gazi I.F., and Elisaf M. LDL-cholesterol calculation formulas in patients with or without the metabolic syndrome. Int J Cardiol 119 (2007) 414-415
16. Eksborg S. Evaluation of method-comparison data. Clin Chem 27 (1981) 1311-1312
17. Knoll E., Hafner F., Dettmer K., et al. The determination of calcium, urea and uric acid using the Kodak Ecktachem multilayer technology: an evaluation. J Clin Chem Clin Biochem 20 (1982) 491-498
18. Harris E.K. Proposed goals for analytical precision and accuracy in the single-point diagnostic testing. Theoretical basis and comparison with data from College of American Pathologists proficiency surveys. Arch Pathol Lab Med 112 (1988) 416-420
19. Painter P.C., Cope J.Y., and Smith J.L. Reference information for the clinical laboratory. In: Burtis C., and Ashwood E. (Eds). Tietz Fundamentals of Clinical Biochemistry. Fifth Edition (2001), WB Saunders Company, Philadelaphia 955-1028
20. McLaughin T., Reaver G., Abbasi F., et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?. Am J Cardiol 96 (2005) 399-404
21. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
22. Nauck M., Warnick G.R., and Rifai N. Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem 48 (2002) 236-254
23. Contois J.H., Gillmor R.G., Moore R.E., Contois L.R.W., Macer J.L., and Wu A.H.B. Quantitative determination of cholesterol in lipoprotein fractions by electrophoresis. Clin Chim Acta 282 (1999) 1-14
24. Benlian P., Cansier C., Hennache G., et al. Comparison of a new method for the direct and simultaneous assessment of LDL- and HDL-cholesterol with ultracentrifugation and established methods. Clin Chem 46 (2000) 493-505
25. Bairaktari E.T., Elisaf M., Tzallas C., Karabina S.A., Tselepis A.D., Siamopoulos K.C., and Tsolas O. Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in haemodialysis patients. Clin Biochem 34 (2001) 593-602
26. Demacker P.N.M., Toenbake-Dijkstra H., de Rijke B., Stalenboef A.F.H., Stuyt P.M.J., and Willems H.L. On the presumed inaccuracy of the Friedewald formula in hypertriglyceridemic plasma: a role for imprecise analysis?. Clin Chem 42 (1996) 1491-1493